In this piece PRISM researchers discuss how the use of artificial intelligence in pathology can open up new pathways towards the early diagnosis of cancer.… Read More »Artificial intelligence in pathology may open the door for many more cancers to be preventable
In the final of our posts regarding the recent major international evaluation of AI in breast cancer screening, we consider how AI could be used… Read More »Artificial Intelligence in breast cancer screening – part 4: personalising screening
In the third of our posts regarding the recent major international evaluation of AI in breast cancer screening, we consider what might be the implications… Read More »Artificial Intelligence in breast cancer screening – part 3: implications for the UK
Previously we reported on a major study evaluating AI as a tool to identify breast cancer on mammography. The results were impressive. In the UK,… Read More »Artificial Intelligence in breast cancer screening – part 2: international differences
Despite many technological advances in mammographic imaging over the last century, breast cancer screening is largely the same as it was when first studied 60… Read More »Artificial Intelligence in breast cancer screening – part 1: are computers developing 20/20 vision?
Following a high-profile article calling for a change in guidelines to make it easier for African Americans to be eligible for lung cancer screening, Prof… Read More »Which screening guidelines are woefully inadequate?
There is an apocryphal story about Queen Victoria. Having enjoyed Alice’s Adventures in Wonderland, the queen requested a copy of Lewis Carroll’s next book. Carroll,… Read More »Isolines and Rabbit Holes: Adventures in ROC Space
The classic American illustration explaining the difference between equity and equality is of three people trying to watch a baseball game from behind a fence.… Read More »Equality and Equity in Cancer Screening: How can we personalise interventions and still be fair?
In our final iconoclasm series post, Peter Sasieni explores the merits of making cancer screening non-binary. The classic paradigm for diagnostic testing and medical screening… Read More »Screening iconoclasm series: Is it time for cancer screening to become non-binary?
In this post, Peter Sasieni argues that it is time to be more specific about our definitions of specificity and false positive tests. How will… Read More »Screening iconoclasm series: Could you be more specific about what you mean by specificity?
